VERA
Vera Therapeutics is a clinical-stage biotechnology company focusing on developing treatments for immunological diseases that improve patients’ lives, with a particular emphasis on IgA nephropathy and related kidney immune disorders. The company conducts research and clinical development to advance therapies for immune-mediated nephropathies, aiming to set new standards in patient care. Its publicly highlighted programs include atacicept in IgAN and other immune-related conditions, with scientific publications and medical affairs supporting clinical insights. Vera Therapeutics operates internationally through a research-driven biopharma approach, communicating its advancements and patient impact through its website and affiliated channels.
No recent news for this company.
No recent deals for this company.